23 C
New York
Thursday, June 11, 2026

Tag: product development

CAREstream America introduces new era of science-backed innovation to deliver a new standard of quality to the US aesthetic market

CAREstream America announces an exclusive distribution partnership to bring Celltermi HS and NX Plus, an advanced probiotic-derived microbiome technology, to the US market. Celltermi...

Cabinetworks Group appoints Danielle Mikesell as new chief commercial officer

LIVONIA, Mich., June 8, 2026 /PRNewswire/ -- Cabinetworks Group, the country's largest privately owned cabinet manufacturer, recently announced it has appointed Danielle Mikesell as...

Smooth Motor Advances Across Robotics and Intelligent Automation Industries Through 30 Years of Rapid Engineering Response

NINGBO, China, June 8, 2026 /PRNewswire/ -- Robotics, semiconductor equipment, and intelligent automation systems are evolving at an accelerating pace, placing OEM manufacturers under...

Zylox-Tonbridge Recognized as Most Honored Company in Extel 2026 Asia Executive Team Survey

HANGZHOU, China, June 8, 2026 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190; "Zylox-Tonbridge" or the "Company"), a Hong Kong-listed medical technology company...

Segway Powersports Showcases AT10 Capability at Red Bull Erzbergrodeo 2026, One of the World’s Toughest Off-Road Races

EISENERZ, Austria, June 8, 2026 /PRNewswire/ -- Segway Powersports recently participated in the 2026 Red Bull Erzbergrodeo in Erzberg, Austria, bringing its AT10 999cc...

Segway Powersports Showcases AT10 Capability at Red Bull Erzbergrodeo 2026, One of the World’s Toughest Off-Road Races

EISENERZ, Austria, June 8, 2026 /CNW/ -- Segway Powersports recently participated in the 2026 Red Bull Erzbergrodeo in Erzberg, Austria, bringing its AT10 999cc...

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) lyophilized vial for intravenous administration.

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment...

Food Safety Testing Market Expected to Reach $44.1 Billion by 2033, at a CAGR of 7% : Allied Market Research

Driven by intensifying food safety requirements with the increased stringency of regulatory guidelines, a substantial and growing incidence of food fraud across global supply...

Food Safety Testing Market Expected to Reach $44.1 Billion by 2033, at a CAGR of 7% : Allied Market Research

Driven by intensifying food safety requirements with the increased stringency of regulatory guidelines, a substantial and growing incidence of food fraud across global supply...

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 1, 2026 (the “Grant Date”), ORIC granted a total of 34,800 non-qualified stock options and 5,900 restricted stock units to two new non-executive employees who began their employment with ORIC in May 2026.

SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver

Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech),...

RAIN Highlights $200M Ecosystem Commitment, $100M Liquidity Expansion, and World Cup Growth Strategy Ahead of Version 2 Launch

Arbitrum-based prediction market protocol prepares for global expansion with AI-powered market resolution, expanded liquidity infrastructure, and upcoming Version 2 release

“Premium Pet Supplies Expo 2026” Officially Opens

Exotic Pets Steal the Spotlight with Debut Reptilia Carnival and Live Insect Exhibition Featuring Over 50 SpeciesHONG KONG, June 5, 2026 /PRNewswire/ -- Organized...

- A word from our sponsors -

spot_img
HomeTagsProduct development